Shilpa Medicare: Financial Results for the Quarter and Half year ended 30 September 2026
Shilpa Medicare (SHILPAMED) filed a disclosure titled "Financial Results for the Quarter and Half year ended 30 September 2026". The company is valued at about ₹18,229 crore.
What happened
Shilpa Medicare (SHILPAMED) filed a disclosure with the exchanges on 5 November 2026 at 01:03 PM titled "Financial Results for the Quarter and Half year ended 30 September 2026".
Company snapshot
Shilpa Medicare is a small-cap company in the Healthcare sector, with a market value of about ₹18,229 crore.
The stock last traded at ₹932.1, against a 52-week range of ₹259.5–₹1,095 (14.9% below the high).
Before this filing the shares had moved −12.4% over the month and +44.6% over three months. Average daily turnover over the last 20 sessions was about ₹74.76 crore.
Promoters held 40.13% at the end of Q1 FY27; 8.73% of promoter shares were pledged. Foreign institutions owned 11.38% and domestic institutions 8.05%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 321 | 46.9 | 4.79 |
| Q2 FY26 | 370 | 44.1 | 2.25 |
| Q3 FY26 | 410 | 44.6 | 2.36 |
| Q4 FY26 | 437 | 107.8 | 5.51 |
| Q1 FY27 | 466 | 100.9 | 5.16 |
What history shows
BCEIE's records show 2 previous results filings from the company since May 2026.
After those filings, the stock gained 6.5% on average the next trading day and was up 14.2% on average after five days (2 filings with price data).
Across 300 similar disclosures by other Healthcare companies, shares moved +1.4% on average the next day and +1.7% over five days; 57% of them rose the next day.
Market-wide, 10,790 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 5 Aug 2026 | Board Meeting Outcome for Unaudited Financial Results For The… | +14.6% | +24.9% |
| 3 Jul 2026 | 'Machine Readable copy of Financial Results '. | −1.5% | +3.5% |
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 5 November 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
- Shilpa Medicare Limited (SHILPAMED.BO) Seasonal Returns Chart - Yahoo Finance
- Shilpa Medicare secures Europe GMP approval for Jadcherla Unit 4
- Shilpa Medicare - Technical picks for Diwali! 10 stocks PL Capital is bullish on this festive season. See full list
- Shilpa Medicare SHILPAMED Q2 FY27 Earnings Call Nov 2026
- Shilpa Medicare reports strong H1 FY27 consolidated profit
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.